CFN Media Interviews Vitality Biopharma (VBIO) CEO Robert Brooke

CFN Media Interviews Robert Brooke of Vitality Biopharma Inc. (PTCQB: VBIO). Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders.

Vitality Biopharma is focused on the discovery and production of cannabinoid glycosides for the treatment of serious neurological and inflammatory diseases. Small molecule glycosylation alters the solubility and stability of drug compounds, and it could extend patent life, improve bioavailability, and reduce side effects through targeted drug delivery.

Currently, most cannabis therapies must be low-dose since THC is absorbed in the blood-brain barrier. The company believes that its prodrug cannabosides could enable targeted delivery of THC molecules into the gut, which would enable higher local concentrations for pain and inflammation in the gastrointestinal tract. The company plans to begin Phase I/II studies this year while taking pathways that involve shorter trials through acute dosing regimens.

Network Partners

Follow Us on Social Media

About CannabisFN

Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of with over a decade of experience educating the markets, profiling public and private companies, and developing specific investor audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and publishes industry news, thought leader and executive interviews, and stories on the fluid business and regulatory environment while serving as a leading corporate communications platform for companies operating in the industry.

Learn How Your Company can Be Covered on CannabisFN

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit:

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer